European CHMP recommends license extension of lacosamide (Vimpat) for idiopathic generalised epilepsy

The license extension is for treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Source:

European Medicines Agency